Stay updated on Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added an NIH grant/contract note for 2014. Updated the page revision to v3.6.6, replacing v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T18:50:14.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added and Revision: v3.6.4 has been removed. This reflects a minor version update to the site's revision label, likely a maintenance or platform update rather than content changes.
    Difference
    0.0%
    Check dated 2026-08-08T10:45:23.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, signaling a new build of the page. This update reflects minor maintenance or version control rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-25T06:25:41.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3. This reflects a new site release rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-07-03T22:09:30.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page's revision tag has been updated to v3.6.2, indicating a newer version of the page. The update does not change study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-26T23:54:18.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    The study record now shows that recruitment is closed and no longer looking for participants. New sections for How to Read a Study Record, Common Questions, and How to Join a Study were added, and the Intervention/Treatment heading was reformatted.
    Difference
    0.4%
    Check dated 2026-06-12T14:18:12.000Z thumbnail image

Stay in the know with updates to Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.